DOI: 10.1055/s-00000019

Fortschritte der Neurologie · Psychiatrie

References

Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J. for the RIO-North America Study Group.
Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factors in Overweight or Obese Patients: RIO-North America: A Randomized Controlled Trial. 
JAMA 2006; 295: 761-775  

Download Bibliographical Data

Search in:
Access:
Access: